Cargando…
MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model
BACKGROUND: One of the most severe complications of the current COVID-19 pandemic is acute respiratory distress syndrome (ARDS). ARDS is caused by increased amounts of pro-inflammatory cytokines, leading to lung damage and loss of lung function. There are currently no effective therapies for combatt...
Autores principales: | Kaspi, Haggai, Semo, Jonathan, Abramov, Nathalie, Dekel, Chen, Lindborg, Stacy, Kern, Ralph, Lebovits, Chaim, Aricha, Revital |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814377/ https://www.ncbi.nlm.nih.gov/pubmed/33468250 http://dx.doi.org/10.1186/s13287-021-02143-w |
Ejemplares similares
-
miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors
por: Gothelf, Yael, et al.
Publicado: (2017) -
NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results
por: Berry, James D., et al.
Publicado: (2019) -
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis
por: Cohen, Jeffrey A, et al.
Publicado: (2022) -
Volatility of molten salts [Ph(4)P][NTf(2)] and Cs[NTf(2)]
por: Zaitsau, Dzmitry H., et al.
Publicado: (2020) -
Filling out the structural map of the NTF2-like superfamily
por: Eberhardt, Ruth Y, et al.
Publicado: (2013)